Stacie Dusetzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.
Federal Policy
Posted inMental Health
Talking 988 with The Takeaway
We share a segment from the public radio show The Takeaway featuring Dan Gorenstein talking about 988.
Posted inMental Health
Answering the Call, Part 3: America’s New Crisis Line Goes Live
In Part 3 of our special series, we hear from individuals working in their communities to prepare for the launch of 988.
Posted inHealth Law
Four Studies to Help You Make Sense of a Post-Roe World
This week our Research Council shares studies to help make sense of a Post-Roe world.
Posted inPublic Health
America’s Chronic Drug Shortage Problem
How one hospital is scrambling to deal with a shortage of a critical drug, and the changes needed to fix chronic supply chain issues.
Posted inCost of Care
Digging Into the Growth in 340B Contract Pharmacies
Paula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Posted inMental Health
Answering the Call, Part 2: Struggling to Staff the Nation’s New Crisis Line
In Part 2 of our 988 series, the scramble to staff the new mental health crisis line and the lessons 988 can learn from 911.
Posted inInsurance
Fixing the Obamacare ‘Glitch’ That Pushed One Couple to Divorce
The Biden administration is trying to close a gap in the Affordable Care Act that blocks 5 million people from getting affordable health care.
Posted inCost of Care
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith. d
Posted inCost of Care
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.